Navigation Links
Revealing the machinery underlying the 'plastic' juvenile brain

Among the central mysteries of neurobiology is what properties of the young brain enable it to so adeptly wire itself to adapt to experience—a quality known as plasticity. The extraordinary plasticity of the young brain occurs only during a narrow window of time known as the critical period. For example, children deprived of normal visual stimulation during an early critical period of the first few years of life suffer the permanent visual impairment of amblyopia.

Now, researchers comparing the genetic machinery of juvenile and adult mouse brains undergoing visual experience have uncovered differences in genetic activity that appear to be central to this plasticity.

Tommaso Pizzorusso and colleagues published their findings in the March 1, 2007 issue of the journal Neuron, published by Cell Press.

In their experiments, after keeping juvenile and adult mice in the dark for three days, the researchers exposed the animals to episodes of normal light and analyzed the response in the genetic machinery of the visual cortex in each animal's brain.

They found that the brains of the juvenile mice showed activation of specific genetic mechanisms that the adult brains did not. Specifically, the researchers found that visual experience in the juvenile brains triggered telltale chemical alterations in substances called histones that were not triggered in the adult brains.

Such histones are protein components of the spools around which DNA winds in chromosomes, and alterations of histones can render the DNA accessible to the machinery that activates genes. The researchers also found that the visual stimulation activated genes known to regulate the transcription of other genes. Transcription is the process of copying DNA genes into RNA, which acts as a blueprint for making proteins.

As a test to determine whether such histone modification functionally affected plasticity, the researchers administered a drug to adult mice th
'"/>

Source:Cell Press


Page: 1 2

Related biology news :

1. Scientists take aim at virulent bacteria by decoding machinery of key control enzyme
2. Gambling monkeys give insight into neural machinery of risk
3. Clearing jams in copy machinery
4. New insight into machinery of immune cells tentacles
5. Dissecting the machinery of nicotines reward
6. Biologists probe the machinery of cellular protein factories
7. Change in gene may be underlying molecular defect in some colorectal cancers
8. New mechanism underlying pain found
9. Researchers reverse juvenile diabetes in animal model
10. A puzzle piece found in unraveling the wiring of the brain
11. Mapping neuron connections in the brain

Post Your Comments:
(Date:11/4/2009)..., PORTOLA VALLEY, Calif., Oct. 19 ...olecular sensing and imaging devices which shed li...that it has signed exclusive distribution deals fo...nsors. The markets covered include Australia, New...enelux), Suriname, Italy, France, Spain, Portugal,...
(Date:11/4/2009)..., RIDGE, N.Y., Oct. 21 What,s the ...eventing accidental death resulting from prescript...s with good intentions, however, may be unaware th...ting their teens from the ticking timebomb of pres...leader in premium-quality medical supplies, has fo...
(Date:11/4/2009)..., CHAPEL HILL Scientists at the University of ...nd the University of California, San Francisco hav...to predict new target diseases for existing drugs....hod that compares how similar the structures of al...ng partners -- known as ligands -- of disease targ...
Breaking Biology News(10 mins):Spectros Signs New International Distribution Deals 2MEDNET Launches MedSafe to Prevent Teenage Prescription Drug Abuse 2MEDNET Launches MedSafe to Prevent Teenage Prescription Drug Abuse 3Study points to new uses, unexpected side effects of already existing drugs 2NSF Emerging Frontiers program supports development of smart materials based on study of fish 9613 1NSF Emerging Frontiers program supports development of smart materials based on study of fish 9613 2NSF Emerging Frontiers program supports development of smart materials based on study of fish 9613 3Kuvan and Naglazyme Data to Be Presented at the 11th Annual ICIEM Meeting 54852 1Kuvan and Naglazyme Data to Be Presented at the 11th Annual ICIEM Meeting 54852 2Kuvan and Naglazyme Data to Be Presented at the 11th Annual ICIEM Meeting 54852 3Kuvan and Naglazyme Data to Be Presented at the 11th Annual ICIEM Meeting 54852 4Kuvan and Naglazyme Data to Be Presented at the 11th Annual ICIEM Meeting 54852 5Kuvan and Naglazyme Data to Be Presented at the 11th Annual ICIEM Meeting 54852 6Martek to Announce Third Quarter 2009 Results 13629 1
...A study has found that the risks of a premature bi...ast two trimesters of pregnancy. The research was ...t de Montral,s Faculty of Pharmacy and the Sainte-...ent Krystel Moussally. , In Canada, 50 percent o... many of them prefer to use natural health product...
... The Aplastic Anemia & MDS International Foundatio...Committee for Medicinal Products for Human Use (CH...inion for the treatment of myelodysplastic syndrom...ll transplants. , The CHMP,s positive opinion is...strated an overall, unprecedented survival benefit...
... Construction of the brain,s border fence is super...t al. in The Journal of Cell Biology ., Like many...security to maintain levels of nutrients and keep ... is a virtually impermeable network of tight junct...ellular flow of materials. Because Wnt/b-catenin s...
Other Biology News:
(Date:11/6/2009).../ -- Intarcia Therapeutics, Inc. delivered two pre...inuous delivery of exenatide) program for the trea...tes Technology Meeting in San Francisco, CA: ,,...301/SFTU126LOGO ) ,, Continuous Subcutaneous ...lucose, HbA1c and Reduces Weight in a 28-day Phase...
(Date:11/5/2009)...re/ -- The endangered black-footed ferrets inhabit...carnivore feeds on prairie dogs. The prairie dog...population die-offs in towns occur. The U.S. Fish...rret breeding program and has been releasing train...itat. Unfortunately, plague can sweep through and...
(Date:11/5/2009)...er 5, 2009 at 4:30 p.m. Eastern Time , BOTHEL...- OncoGenex Pharmaceuticals, Inc. ("OncoGenex" or ...udited financial results for the third quarter and... the Company,s highlights for the third quarter of...flect the operations of OncoGenex Technologies Inc...
(Date:11/5/2009)...re-FirstCall/ -- Wound Management Technologies, In...to a Letter of Intent to purchase all healthcare-r... (OTC Bulletin Board: VHGI). The deal provides for...0,000 shares of WNDM and a royalty agreement for r...ogy being acquired from VHGI. WNDM closed at $2....
Breaking Biology Technology:Intarcia Therapeutics, Inc. Presents Positive Results from Two Studies of ITCA 650 for the Treatment of Type 2 Diabetes at the Ninth Annual Diabetes Technology Meeting 2Intarcia Therapeutics, Inc. Presents Positive Results from Two Studies of ITCA 650 for the Treatment of Type 2 Diabetes at the Ninth Annual Diabetes Technology Meeting 3Intarcia Therapeutics, Inc. Presents Positive Results from Two Studies of ITCA 650 for the Treatment of Type 2 Diabetes at the Ninth Annual Diabetes Technology Meeting 4Intarcia Therapeutics, Inc. Presents Positive Results from Two Studies of ITCA 650 for the Treatment of Type 2 Diabetes at the Ninth Annual Diabetes Technology Meeting 5Colorado Companies Team Up With U.S. Fish & Wildlife Service to Protect Black-Footed Ferret 2OncoGenex Reports Third Quarter 2009 Financial Results 2OncoGenex Reports Third Quarter 2009 Financial Results 3OncoGenex Reports Third Quarter 2009 Financial Results 4OncoGenex Reports Third Quarter 2009 Financial Results 5OncoGenex Reports Third Quarter 2009 Financial Results 6OncoGenex Reports Third Quarter 2009 Financial Results 7OncoGenex Reports Third Quarter 2009 Financial Results 8OTCBB-WNDM Announces LOI to Acquire VHGI Assets for $10 Million Cash/Stock 2OTCBB-WNDM Announces LOI to Acquire VHGI Assets for $10 Million Cash/Stock 3
...ewswire/ -. Actavis Group, the,international gener...t has,received approval from the U.S. Food & Drug ...em. Distribution of the product will begin,immedia...equivalent of Alza/Janssen,s,Duragesic(R) and avai...ntanyl Transdermal System is indicated for the man...
...otechnology Company confirms commercial expression... status of native Apo AI -, CALGARY, Aug. 22 /PRN...SBS), a biotechnology company developing a portfol...ovascular diseases, today updated a release,issued...achieved commercial,levels of apolipoprotein AI (n...
...epublic, Aug. 21 Medpace,Inc., a leading global f...announced it has completed the acquisition of Mona...n (CRO) headquartered in Prague, Czech,Republic. T...al Europe and,expands its capacity to provide full...zech Republic and Slovakia. Petr Potuznik, MD, the...
Other Biology Technology:Actavis Receives Approval of Fentanyl Transdermal System in the U.S. 2SemBioSys updates Apo AI development program 2SemBioSys updates Apo AI development program 3SemBioSys updates Apo AI development program 4Medpace Strengthens Presence in Central Europe 2
Mouse Anti-Human p53, wild & mutant, aa 19-26 Monoclonal Antibody, Unconjugated, Clone DO-7 from CHEMICON
Tube-O-DIALYZER Floats, Floats, Small from CHEMICON
Anti-Feline Rhinotracheitis Virus Monoclonal Antibody, Unconjugated from ViroStat Inc.
Anti-Ezrin / Radixin / Moesin Antibody, Unconjugated from Cell Signaling Technology
Biology Products: